Literature DB >> 376316

Results of two sequential chemotherapy studies in WHO Types I, III and IV lung cancer: cyclophosphamide-5-fluorouracil (CF) and cyclophosphamide-5-fluorouracil-adriamycin (CAF).

A Brugarolas, A J Lacave, A Ribas, J M Buesa, M T Garcia Miralles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 376316     DOI： 10.1016/0014-2964(79)90044-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  2 in total

1.  Failure of intensive combination therapy (cyclophosphamide, adriamycin, 5-fluorouracil) to control adenocarcinoma or large-cell anaplastic carcinoma of lung.

Authors:  R E Taylor; I E Smith; H T Ford; B M Bryant; A J Casey; J F Smyth
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

2.  Experimental combination and single-agent chemotherapy in human lung-tumour xenografts.

Authors:  A J Shorthouse; J M Jones; G G Steel; M J Peckham
Journal:  Br J Cancer       Date:  1982-07       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.